Cargando…
Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
OBJECTIVE: Microvascular obstruction (MVO) and intramyocardial haemorrhage (IMH) are known complications of myocardial ischaemia-reperfusion injury. Whereas MVO is an established marker for a poor clinical outcome, the clinical significance of IMH remains less well defined. Cardiovascular MR (CMR) a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838761/ https://www.ncbi.nlm.nih.gov/pubmed/27110375 http://dx.doi.org/10.1136/openhrt-2015-000346 |
_version_ | 1782428027560394752 |
---|---|
author | Hansen, Esben Søvsø Szocska Pedersen, Steen Fjord Pedersen, Steen Bønløkke Kjærgaard, Uffe Schmidt, Nikolaj Hjort Bøtker, Hans Erik Kim, Won Yong |
author_facet | Hansen, Esben Søvsø Szocska Pedersen, Steen Fjord Pedersen, Steen Bønløkke Kjærgaard, Uffe Schmidt, Nikolaj Hjort Bøtker, Hans Erik Kim, Won Yong |
author_sort | Hansen, Esben Søvsø Szocska |
collection | PubMed |
description | OBJECTIVE: Microvascular obstruction (MVO) and intramyocardial haemorrhage (IMH) are known complications of myocardial ischaemia-reperfusion injury. Whereas MVO is an established marker for a poor clinical outcome, the clinical significance of IMH remains less well defined. Cardiovascular MR (CMR) and T2 weighted short tau inversion recovery (T2-STIR) imaging have been used to detect IMH and to explore its clinical importance. IMH is typically identified within the area-at-risk as a hypointense signal core on T2-STIR images. Because MVO will also appear as a hypointense signal core, T2-STIR imaging may not be an optimal method for assessing IMH. In this study, we sought to investigate the ability of T2-STIR to discriminate between MVO with IMH in a porcine myocardial ischaemia-reperfusion model that expressed MVO with and without IMH. METHOD: MVO with and without IMH (defined from both macroscopic evaluation and T1 weighted CMR) was produced in 13 pigs by a 65-min balloon occlusion of the mid left anterior descending artery, followed by reperfusion. Eight days after injury, all pigs underwent CMR imaging and subsequently the hearts were assessed by gross pathology. RESULTS: CMR identified MVO in all hearts. CMR and pathology showed that IMH was present in 6 of 13 (46%) infarcts. The sensitivity and specificity of T2-STIR hypointense signal core for identification of IMH was 100% and 29%, respectively. T2-values between hypointense signal core in the pigs with and without IMH were similar (60.4±3 ms vs 63.0±4 ms). CONCLUSIONS: T2-STIR did not allow identification of IMH in areas with MVO in a porcine model of myocardial ischaemic/reperfusion injury in the subacute phase of a reperfused myocardial infarction. |
format | Online Article Text |
id | pubmed-4838761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48387612016-04-22 Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction Hansen, Esben Søvsø Szocska Pedersen, Steen Fjord Pedersen, Steen Bønløkke Kjærgaard, Uffe Schmidt, Nikolaj Hjort Bøtker, Hans Erik Kim, Won Yong Open Heart Basic and Translational Research OBJECTIVE: Microvascular obstruction (MVO) and intramyocardial haemorrhage (IMH) are known complications of myocardial ischaemia-reperfusion injury. Whereas MVO is an established marker for a poor clinical outcome, the clinical significance of IMH remains less well defined. Cardiovascular MR (CMR) and T2 weighted short tau inversion recovery (T2-STIR) imaging have been used to detect IMH and to explore its clinical importance. IMH is typically identified within the area-at-risk as a hypointense signal core on T2-STIR images. Because MVO will also appear as a hypointense signal core, T2-STIR imaging may not be an optimal method for assessing IMH. In this study, we sought to investigate the ability of T2-STIR to discriminate between MVO with IMH in a porcine myocardial ischaemia-reperfusion model that expressed MVO with and without IMH. METHOD: MVO with and without IMH (defined from both macroscopic evaluation and T1 weighted CMR) was produced in 13 pigs by a 65-min balloon occlusion of the mid left anterior descending artery, followed by reperfusion. Eight days after injury, all pigs underwent CMR imaging and subsequently the hearts were assessed by gross pathology. RESULTS: CMR identified MVO in all hearts. CMR and pathology showed that IMH was present in 6 of 13 (46%) infarcts. The sensitivity and specificity of T2-STIR hypointense signal core for identification of IMH was 100% and 29%, respectively. T2-values between hypointense signal core in the pigs with and without IMH were similar (60.4±3 ms vs 63.0±4 ms). CONCLUSIONS: T2-STIR did not allow identification of IMH in areas with MVO in a porcine model of myocardial ischaemic/reperfusion injury in the subacute phase of a reperfused myocardial infarction. BMJ Publishing Group 2016-04-20 /pmc/articles/PMC4838761/ /pubmed/27110375 http://dx.doi.org/10.1136/openhrt-2015-000346 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Basic and Translational Research Hansen, Esben Søvsø Szocska Pedersen, Steen Fjord Pedersen, Steen Bønløkke Kjærgaard, Uffe Schmidt, Nikolaj Hjort Bøtker, Hans Erik Kim, Won Yong Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction |
title | Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction |
title_full | Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction |
title_fullStr | Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction |
title_full_unstemmed | Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction |
title_short | Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction |
title_sort | cardiovascular mr t2-stir imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction |
topic | Basic and Translational Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838761/ https://www.ncbi.nlm.nih.gov/pubmed/27110375 http://dx.doi.org/10.1136/openhrt-2015-000346 |
work_keys_str_mv | AT hansenesbensøvsøszocska cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction AT pedersensteenfjord cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction AT pedersensteenbønløkke cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction AT kjærgaarduffe cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction AT schmidtnikolajhjort cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction AT bøtkerhanserik cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction AT kimwonyong cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction |